Table 1 Characteristics of the population and of male and female patients

Age (years)

11

(10–12)

11

(10–12)

11

(9–12)

0.961

Females

31

(49.2%)

BMI z-score

2.64

(2.46–3.04)

2.65

(2.25–3.04)

2.62

(2.47–3.05)

0.437

TMI (Kg/m³)

18.01

(16.87–19.68)

18.51

(17.09-19-92)

17.64

(16.48–19.26)

0.093

WC (cm)

88

(83–96)

87

(83–96)

89

(82–96)

0.544

WHR

0.59

(0.56–0.62)

0.59

(0.55–0.63)

0.59

(0.57–0.62)

0.564

ABSI

0.080

(0.076–0.082)

0.077

(0.074–0.081)

0.081

(0.078–0.083)

0.006*

ABSI z-score

0.223

(-0.697, 0.837)

-0.449

(-1.209, 0.500)

0.629

(-0.113, 1.173)

0.005*

HOMA-IR

3.34

(2.22–5.06)

3.69

(2.26–5.98)

3.34

(2.17–4.51)

0.326

HOMA β

260.1

(194.1-333.6)

293.6

(216.0-447.7)

251.2

(142.0-285.6)

0.025*

QUICKI

0.32

(0.30–0.34)

0.31

(0.30–0.34)

0.32

(0.31–0.34)

0.256

Office SBP (mmHg)

114

(117–120)

113

(110–120)

115

(107–123)

0.705

Office DBP (mmHg)

62

(58–60)

60

(58–70)

64

(59–70)

0.388

IVSd (cm)

0.7

(0.7–0.8)

0.7

(0.7–0.8)

0.7

(0.7–0.8)

0.762

LVEDD (cm)

4.2

(4.0-4.5)

4.2

(3.7–4.3)

4.4

(4.0-4.6)

0.012*

LVPWd (cm)

0.7

(0.7–0.8)

0.7

(0.6–0.8)

0.7

(0.7–0.8)

0.248

EF (%)

64

(62–65)

64

(62–66)

63

(61–65)

0.229

LVMI (g/m³)

29.8

(26.0–33.4)

27.5

(24.9–32.4)

30.8

(27.9–35.6)

0.012*

LV Hypertrophy

14

(22.2%)

24

(77%)

25

(78%)

0.592

Mean 24-hour SBP (mmHg)

111

(106–117)

110

(105–116)

112

(106–119)

0.417

Mean 24-hour DBP (mmHg)

70

(67–73)

69

(66–72)

71

(69–74)

0.035*

Mean daytime SBP (mmHg)

117

(113–123)

115

(111–121)

119

(114–125)

0.090

Mean daytime DBP (mmHg)

75

(72–80)

74

(70–78)

77

(72–82)

0.014*

Mean night-time SBP (mmHg)

101

(96–109)

100

(97–108)

103

(95–110)

0.934

Mean night-time DBP (mmHg)

61

(59–65)

61

(59–63)

63

(58–67)

0.151

Hypertension at ABPM

22

(35%)

23

(74%)

18

(56%)

0.109

Non dipper

18

(28.6%)

20

(65%)

25

(78%)

0.180